1.
Oncology (Williston Park)
; 33(11)2019 11 14.
Article
in English
| MEDLINE
| ID: mdl-31769867
2.
Oncology (Williston Park)
; 33(9)2019 Sep 20.
Article
in English
| MEDLINE
| ID: mdl-31571181
3.
Oncology (Williston Park)
; 33(10)2019 10 28.
Article
in English
| MEDLINE
| ID: mdl-31661150
ABSTRACT
The year 2019 has offered up many advances in immunotherapy. These advances shed light on such important aspects as biomarkers, better targeted therapies, chemotherapy outcomes, and resistance. Summarized herein are several high-profile conference presentations that highlight key advances in the field.
Subject(s)
Antineoplastic Agents/therapeutic use , Clinical Trials as Topic/statistics & numerical data , Immunotherapy/methods , Molecular Targeted Therapy/methods , Neoplasms/drug therapy , Humans , Immunotherapy/trends , Molecular Targeted Therapy/trends , Neoplasms/immunology , Prognosis
4.
Oncology (Williston Park)
; 33(8)2019 08 23.
Article
in English
| MEDLINE
| ID: mdl-31469902
Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , B7-H1 Antigen/antagonists & inhibitors , Carcinoma, Non-Small-Cell Lung/drug therapy , Lung Neoplasms/drug therapy , Small Cell Lung Carcinoma/drug therapy , Triple Negative Breast Neoplasms/drug therapy , Antibodies, Monoclonal, Humanized/administration & dosage , Antineoplastic Agents, Immunological/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Drug Approval , Humans , Neoplasm Metastasis , Survival Rate , Treatment Outcome
5.
Oncology (Williston Park)
; 33(8)2019 08 23.
Article
in English
| MEDLINE
| ID: mdl-31469903
Subject(s)
Aniline Compounds/therapeutic use , Leukemia, Myeloid, Acute/drug therapy , Neoplasm Recurrence, Local/drug therapy , Pyrazines/therapeutic use , Clinical Trials, Phase III as Topic , Drug Approval , Drug Resistance, Neoplasm , Humans , Leukemia, Myeloid, Acute/genetics , Leukemia, Myeloid, Acute/pathology , Mutation , Neoplasm Recurrence, Local/genetics , Neoplasm Recurrence, Local/pathology , Protein Kinase Inhibitors/therapeutic use , Salvage Therapy , Survival Rate , Treatment Outcome , fms-Like Tyrosine Kinase 3/genetics
6.
7.
Oncology (Williston Park)
; 33(7)2019 07 15.
Article
in English
| MEDLINE
| ID: mdl-31365755
Subject(s)
BRCA1 Protein/genetics , BRCA2 Protein/genetics , Drug Approval , Mutation , Ovarian Neoplasms/drug therapy , Phthalazines/therapeutic use , Piperazines/therapeutic use , Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use , Female , Humans , Progression-Free Survival , Randomized Controlled Trials as Topic , Treatment Outcome , United States , United States Food and Drug Administration
8.
Oncology (Williston Park)
; 33(5): 186, 2019 05 14.
Article
in English
| MEDLINE
| ID: mdl-31095718
Subject(s)
Antibodies, Monoclonal, Humanized/administration & dosage , Antineoplastic Agents, Immunological/administration & dosage , Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Renal Cell/drug therapy , Dosage Forms , Drug Approval/methods , Humans , Kidney Neoplasms/drug therapy , Lung Neoplasms/drug therapy , United States , United States Food and Drug Administration
9.
Oncology (Williston Park)
; 33(2): 78, 2019 Feb 15.
Article
in English
| MEDLINE
| ID: mdl-30784035
Subject(s)
Colorectal Neoplasms/microbiology , Gastrointestinal Microbiome/physiology , Bile Acids and Salts/metabolism , Colorectal Neoplasms/mortality , Colorectal Neoplasms/therapy , Colorectal Neoplasms, Hereditary Nonpolyposis/microbiology , Dietary Fiber/administration & dosage , Fatty Acids, Omega-3/administration & dosage , Humans , Metagenomics , Sulfur/metabolism
10.
Oncology (Williston Park)
; 33(1): 6-8, 2019 Jan 17.
Article
in English
| MEDLINE
| ID: mdl-30731011
Subject(s)
Biomedical Research , Medical Oncology/trends , Neoplasms/therapy , Breast Neoplasms/therapy , Female , Hematologic Neoplasms/therapy , Humans , Male
11.
Oncology (Williston Park)
; 33(1): 8-10, 2019 01 17.
Article
in English
| MEDLINE
| ID: mdl-30731012